Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Open accessThe DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.
Abstract
Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent studies indicated that CAFs consist of several types of stromal cells that differ in their origin, functions, number, and phenotype [21, 22, 23, 24].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedSun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., CHEN, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.224 · Cited by 40
RetractedChen, L., Qu, C., Chen, H., Xu, L., Qi, Q., Luo, J., Wang, K., Meng, Z., Chen, Z., Wang, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096177 · Cited by 30
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“This phenomenon is known as “Warburg effect” [84].”
BackgroundThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“proposed the theory that a “tumor is a wound that never heals” [2].”
BackgroundThe Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 2×
“These myofibroblasts acquire de novo expressed α-SMA, contractile stress fibers, and the ED-A splice variant of fibronectin [5,7].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Cited by
Items 301–400 of 814
Wu, Z., Tang, Y., Liu, Y., Chen, Z., Feng, Y., Hu, H., Liu, H., Chen, G., Lu, Y., Hu, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.017 · Cited by 36
Necrosis in the Tumor Microenvironment and Its Role in Cancer Recurrence
Karsch-Bluman, A., & Benny, O. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_6 · Cited by 37
Ovarian Cancer Exosomes Trigger Differential Biophysical Response in Tumor-Derived Fibroblasts
Lee, A. H., Ghosh, D., Quach, N. D., Schroeder, D., & Dawson, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65628-3 · Cited by 34
Balaji, S., Kim, U. R., Muthukkaruppan, V., & Vanniarajan, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119750 · Cited by 36
Koppensteiner, L., Mathieson, L., Pattle, S. B., Dorward, D. A., O’Connor, R. A., & Akram, A. R. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006770 · Cited by 34
Rutherford, E. J., Hill, A. D. K., & Hopkins, A. M. (2018) · Cells · doi:10.3390/cells7050043 · Cited by 33
Zhang, J., Wang, Q., & Quan, Z. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.080 · Cited by 34
Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer
Verma, A., Schwartz, N., Cohen, D. J., Boyan, B. D., & Schwartz, Z. (2019) · Steroids · doi:10.1016/j.steroids.2019.108498 · Cited by 37
Prostate Cancer Energetics and Biosynthesis
Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M. A., McGuire, S. E., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_10 · Cited by 39
The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity
Fico, F., & Santamaria‐Martínez, A. (2020) · Cancers · doi:10.3390/cancers12123863 · Cited by 35
Stromal disruption facilitating invasion of a ‘nano-arsenal’ into the solid tumor
Fu, Y., Saraswat, A. L., Monpara, J. D., & Patel, K. R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.015 · Cited by 33
Oo, M. W., Kawai, H., Takabatake, K., Tomida, S., Eguchi, T., Ono, K., Shan, Q., Ohara, T., Yoshida, S., Omori, H., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148960 · Cited by 35
Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden, D., Zaheer, S., Ahluwalia, H., & Ranga, S. (2023) · Cell Biology International · doi:10.1002/cbin.12004 · Cited by 33
Tumor microenvironment – Unknown niche with powerful therapeutic potential
Kolenda, T., Przybyła, W., Kapałczyńska, M., Teresiak, A., Zajączkowska, M. M., Bliźniak, R., & Lamperska, K. M. (2018) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2018.01.004 · Cited by 33
Wanandi, S. I., Ningsih, S. S., Asikin, H., Hosea, R., & Neolaka, G. M. G. (2018) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2018.25.3.2 · Cited by 35
Engineering Targeting Materials for Therapeutic Cancer Vaccines
Briquez, P. S., Hauert, S., de Titta, A., Gray, L. T., Alpar, A. T., Swartz, M. A., & Hubbell, J. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00019 · Cited by 32
Exosome-transmitted circ IFNGR2 Modulates Ovarian Cancer Metastasis via miR-378/ST5 Axis
Chen, X., Ren, X., Jiaoting, E., Zhou, Y., & Bian, R. (2023) · Molecular and Cellular Biology · doi:10.1080/10985549.2022.2160605 · Cited by 34
Tian, H., Ou, J., Wang, Y., Sun, J., Gao, J., Ye, Y., Zhang, R., Chen, B., Wang, F., Huang, W., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.016 · Cited by 32
Wawro, M. E., Sobierajska, K., Ciszewski, W. M., & Niewiarowska, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081941 · Cited by 33
Zhu, J., Zhang, K., Chen, Y., Ge, X., Wu, J., Xu, P., & Yao, J. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05307-3 · Cited by 34
Hussain, Q. M., Al-Hussainy, A. F., Sanghvi, G. V., Roopashree, R., Kashyap, A., Anand, D. A., Panigrahi, R., Shavazi, N., Taher, S. G., Alwan, M., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02618-z · Cited by 32
Acquired resistance to molecularly targeted therapies for cancer
Stubbs, N. M., Roady, T. J., Schwermann, M. P., Eteshola, E. O. U., MacDonald, W., Purcell, C., Ryspayeva, D., Verovkina, N., Tajiknia, V., Ghandali, M., et al. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.189 · Cited by 41
Fujisawa, M., Moh-Moh-Aung, A., Zeng, Z., Yoshimura, T., Wani, Y., & Matsukawa, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205494 · Cited by 36
MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
Ast, V., Kordaß, T., Oswald, M., Kolte, A., Eisel, D., Osen, W., Eichmüller, S. B., Berndt, A., & König, R. (2018) · Oncotarget · doi:10.18632/oncotarget.26263 · Cited by 33
Николаевна, Д. И., Shirmanova, M. V., Ignatova, N. I., Dudenkova, V. V., Lukina, M. M., Вадимовна, З. Е., Safina, D. R., Kostrov, S. V., Didych, D. A., Kuzmich, A. I., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218119 · Cited by 33
Melanoma Progression under Obesity: Focus on Adipokines
Olszańska, J., Pietraszek‐Gremplewicz, K., & Nowak, D. (2021) · Cancers · doi:10.3390/cancers13092281 · Cited by 31
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
Marques, P., Silva, A. L., Lopéz‐Presa, D., Faria, C. C., & Bugalho, M. J. (2022) · Pituitary · doi:10.1007/s11102-022-01211-5 · Cited by 33
Role of 68Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies: A Prospective Pilot Study
Rajaraman, V., Meenakshi, L. A., Selvaraj, A. J., Pottakkat, B., & Halanaik, D. (2023) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004641 · Cited by 32
Jeong, S., Tong, Y., Sha, M., Gu, J., & Xia, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.14079 · Cited by 31
Interferon-γ and Colorectal Cancer: an up-to date
Kosmidis, C. S., Sapalidis, K. G., Κoletsa, T., Kosmidou, M. S., Efthimiadis, C., Anthimidis, G., Varsamis, N., Michalopoulos, N., Koulouris, C., Atmatzidis, S. K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.22962 · Cited by 36
Geng, F., Guo, J., Guo, Q., Xie, Y., Dong, L., Zhou, Y., Liu, C., Yu, B., Wu, H., Wu, J., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.012 · Cited by 32
Shimada, C., Xu, R. F., Al-Alem, L., Stasenko, M., Spriggs, D. R., & Rueda, B. R. (2020) · Cancers · doi:10.3390/cancers12061421 · Cited by 30
Liu, Y., Fu, W., Cao, X., Li, S., Xiong, T., Zhang, X., Wu, X., Cheng, L., Wei, Y., & Gao, B. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/5517747 · Cited by 30
RetractedNotch signaling in female cancers: a multifaceted node to overcome drug resistance
Giuli, M. V., Mancusi, A., Giuliani, E., Screpanti, I., & Checquolo, S. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.53 · Cited by 31
Senescent Fibroblasts Generate a CAF Phenotype through the Stat3 Pathway
Li, H., Qiu, L., Liu, Q., Ma, Z., Xie, X., Luo, Y., & Wu, X. (2022) · Genes · doi:10.3390/genes13091579 · Cited by 30
Itoh, R. A., Uyama, N., Hirota, S., Kawada, N., Wu, S., Miyashita, S., Nakamura, I., Suzumura, K., Sueoka, H., Okada, T., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.08.016 · Cited by 32
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
Le, Q., Suh, J., & Oh, Y. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0333-y · Cited by 31
Movia, D., Bazou, D., & Prina‐Mello, A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6038-x · Cited by 34
Significance of stroma in biology of oral squamous cell carcinoma
Boras, V. V., Fučić, A., Virag, M., Gabrić, D., Blivajs, I., Tomasović‐Lončarić, Č., Rakušić, Z., Bišof, V., Novère, N. G. L., & Vrdoljak, D. V. (2017) · Tumori Journal · doi:10.5301/tj.5000673 · Cited by 29
Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients
Hu, G., Xu, F., Zhong, K., Wang, S., Huang, L., & Chen, W. (2018) · Journal of Cancer · doi:10.7150/jca.28054 · Cited by 29
Interleukin-34 Enhances the Tumor Promoting Function of Colorectal Cancer-Associated Fibroblasts
Franzè, E., Grazia, A. D., Sica, G. S., Biancone, L., Laudisi, F., & Monteleone, G. (2020) · Cancers · doi:10.3390/cancers12123537 · Cited by 29
Alhussan, A., Bromma, K., Mesa-Perez, M., Beckham, W., Alexander, A., Howard, P. L., & Chithrani, D. B. (2021) · Cancers · doi:10.3390/cancers13133157 · Cited by 29
Pradip, D., Aske, J. C., & Dey, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179121 · Cited by 31
Feng, T., Fang, F., Zhang, C., Li, T., He, J., Shen, Y., Yu, H., & Liu, X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703104 · Cited by 30
Mechanobiology of Colorectal Cancer
Brás, M. M., Sousa, S. R., Carneiro, F., Radmacher, M., & Granja, P. L. (2022) · Cancers · doi:10.3390/cancers14081945 · Cited by 34
The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance
Fromme, J. E., & Zigrino, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.864302 · Cited by 31
Tumour microenvironment and pituitary tumour behaviour
Marques, P., & Korbonits, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02089-1 · Cited by 29
Kryza, T., Silva, L. M., Bock, N., Fuhrman‐Luck, R. A., Stephens, C. R., Gao, J., Samaratunga, H., BioResource, A. P. C., Lawrence, M. G., Hooper, J. D., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12075 · Cited by 29
Neuroendocrine tumours and their microenvironment
de Hosson, L. D., Takkenkamp, T. J., Kats‐Ugurlu, G., Bouma, G., Bulthuis, M. L. C., de Vries, E. G. E., van Faassen, M. H. J. R., Kema, I. P., & Walenkamp, A. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02556-1 · Cited by 29
Teng, C., Zhang, B., Yuan, Z., Kuang, Z., Chai, Z., Ren, L., Qin, C., Yang, L., Han, X., & Yin, L. (2020) · Nanoscale · doi:10.1039/d0nr04465b · Cited by 29
Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy
Yu, Y., Li, K., Peng, Y., Zhang, Z., Pu, F., Shao, Z., & Wu, W. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101569 · Cited by 39
Wang, M., Zhao, Y., Xu, K., Liu, C., Zhong, H., Wu, Y., Zhang, K., & Wei, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617968 · Cited by 34
IL-1β Induces Fascin Expression and Increases Cancer Invasion
LEE, M. K., Park, J. H., Gi, S. H., & Hwang, Y. S. (2018) · Anticancer Research · doi:10.21873/anticanres.12964 · Cited by 28
Esmaeili, J., Barati, A., Ai, J., Nooshabadi, V. T., & Mirzaei, Z. (2021) · RSC Advances · doi:10.1039/d1ra00855b · Cited by 29
Geng, F., Dong, L., Bao, X., Guo, Q., Guo, J., Zhou, Y., Yu, B., Wu, H., Wu, J., Zhang, H., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.07.008 · Cited by 28
Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor Immunity
Kracht, M. J. L., Zaldumbide, A., & Roep, B. O. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.013 · Cited by 30
Xu, Z., Zheng, X., & Zheng, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10740 · Cited by 31
Fabbri, F., Salvi, S., & Bravaccini, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.015 · Cited by 28
YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
Xiao, Y., Zhou, L., Andl, T., & Zhang, Y. (2024) · Oncogene · doi:10.1038/s41388-024-02953-1 · Cited by 30
Ravi, K., Zhang, Y., Sakala, L., Manoharan, T. J. M., Pockaj, B. A., LaBaer, J., Park, J. G., & Nikkhah, M. (2025) · Advanced Science · doi:10.1002/advs.202413457 · Cited by 29
Darvishi, B., Majidzadeh‐A, K., Ghadirian, R., Mosayebzadeh, M., & Farahmand, L. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.033 · Cited by 27
Bone Marrow Stromal Cells Drive Key Hallmarks of B Cell Malignancies
Mangolini, M., & Ringshausen, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041466 · Cited by 29
Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment
Mandal, D., Paul, P., & Bhowmik, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821712-2.00003-7 · Cited by 28
Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer
Wang, M., Xue, W., Yuan, H., Wang, Z., & Yu, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s451151 · Cited by 29
Superoxide Dismutases in Pancreatic Cancer
Wilkes, J. G., Alexander, M. S., & Cullen, J. J. (2017) · Antioxidants · doi:10.3390/antiox6030066 · Cited by 29
Iglesias, V. S., Theys, J., Groot, A. J., Barbeau, L. M. O., Lemmens, A., Yaromina, A., Losen, M. H., Houben, R. M. A., Dubois, L. J., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00460 · Cited by 27
Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs
Naruse, M., Ochiai, M., Sekine, S., Taniguchi, H., Yoshida, T., Ichikawa, H., Sakamoto, H., Kubo, T., Matsumoto, K., Ochiai, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81475-2 · Cited by 29
Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity
Horiguchi, H., Kadomatsu, T., Kurahashi, R., Hara, C., Miyata, K., Baba, M., Osumi, H., Terada, K., Araki, K., Takai, T., et al. (2019) · Genes & Development · doi:10.1101/gad.329417.119 · Cited by 28
Musa, M., & Ali, A. (2020) · Future Oncology · doi:10.2217/fon-2020-0384 · Cited by 28
Mukkamala, R., Lindeman, S. D., Kragness, K. A., Shahriar, I., Srinivasarao, M., & Low, P. S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02651h · Cited by 25
Sugai, T., Uesugi, N., Kitada, Y., Yamada, N., Osakabe, M., Eizuka, M., Sugimoto, R., Fujita, Y., Kawasaki, K., Yamamoto, E., et al. (2018) · Journal of Cancer · doi:10.7150/jca.25646 · Cited by 27
Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells Ontumor Growth and Progression
Rahmatizadeh, F., Aziz, S. G., Khodadadi, K., Ataei, M. L., Ebrahimie, E., Rad, J. S., & Pashaiasl, M. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.063 · Cited by 26
Li, X., Song, Q., Guo, X., Wang, L., Zhang, Q., Cao, L., Ren, Y., Wu, X., Meng, Z., & Xu, K. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s246235 · Cited by 26
Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy
Rastegar‐Pouyani, N., Abdolvahab, M. H., Farzin, M. A., Zare, H., Kesharwani, P., & Sahebkar, A. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102624 · Cited by 25
Li, Q., Li, M., Zheng, K., Tang, S., & Ma, S. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100891 · Cited by 25
Modelling TGFβR and Hh pathway regulation of prognostic matrisome molecules in ovarian cancer
Delaine‐Smith, R. M., Maniati, E., Malacrida, B., Nichols, S., Roozitalab, R., Jones, R. R., Lecker, L. S. M., Pearce, O. M. T., Knight, M. M., & Balkwill, F. R. (2021) · iScience · doi:10.1016/j.isci.2021.102674 · Cited by 27
Kuznetsova, A. V., Попова, О. П., Panchenkov, D. N., Dyuzheva, Т. G., & Aa, I. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00886-1 · Cited by 24
The paradox of cooperation among selfish cancer cells
Capp, J., Thomas, F., Marusyk, A., Dujon, A. M., Tissot, S., Gatenby, R. A., Roche, B., Újvári, B., DeGregori, J. V., Brown, J. S., et al. (2023) · Evolutionary Applications · doi:10.1111/eva.13571 · Cited by 24
A Scaffold-Free 3-D Co-Culture Mimics the Major Features of the Reverse Warburg Effect In Vitro
Keller, F., Bruch, R., Schneider, R., Meier-Hubberten, J. C., Hafner, M., & Rudolf, R. (2020) · Cells · doi:10.3390/cells9081900 · Cited by 24
MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
Lee, N., Kim, S. J., & Hyun, J. (2021) · Biomedicines · doi:10.3390/biomedicines9040347 · Cited by 26
Su, S., Ho, H. H., Li, J.-H., Wu, M., Wang, H.-C., Yeh, H., Kuo, S., Chen, H., Ho, C., & Li, K.-C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139552 · Cited by 24
Romani, A., Casciano, F., Stevanin, C., Maietti, A., Tedeschi, P., Secchiero, P., Marchetti, N., & Voltan, R. (2021) · Molecules · doi:10.3390/molecules26216369 · Cited by 24
Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers
Cheng, L., Zhang, L., Wang, X., Wang, Y., Yu, J., Li, M., Ma, Z., Ho, P. C., Chen, X., Wang, L., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107419 · Cited by 24
Liu, C., Wang, Y., Kuo, F., Hsu, W., Yu, F., Hsieh, S., Tai, M., Wu, D., & Kuo, C. (2018) · Cancers · doi:10.3390/cancers10120479 · Cited by 25
Li, X., Zhou, Q., Wang, S., Wang, P., Li, J., Xie, Z., Liu, C., Wen, J., & Wu, X. (2020) · Aging · doi:10.18632/aging.103910 · Cited by 24
Holter, J. C., Chang, C.-S., Avendano, A., Garg, A. A., Verma, A. K., Charan, M., Ahirwar, D. K., Ganju, R. K., & Song, J. W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.888431 · Cited by 24
Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications
Franquet, E., & Park, H. (2022) · European Journal of Radiology Open · doi:10.1016/j.ejro.2022.100455 · Cited by 24
Zhou, X., Zhang, P., Liu, N., Zhang, X., Lv, H., Xu, W., & Huo, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.061 · Cited by 23
Targeting the prostate tumor microenvironment by plant-derived natural products
Wu, J., Ji, H., Li, T., Guo, H., Xu, H., Zhu, J., Tian, J., Gao, M., Wang, X., & Zhang, A. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.111011 · Cited by 25
Interfacial Adipose Tissue in Systemic Sclerosis
Kruglikov, I. L. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0627-y · Cited by 23
Eckhardt, B. L., Gagliardi, M. E., Iles, L. R., Evans, K. W., Ivan, C., Liu, X., Liu, C., Souza, G. R., Rao, A. U. K., Meric‐Bernstam, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195932 · Cited by 23
Vallejo-Ardila, D. L., Fifis, T., Burrell, L. M., Walsh, K. A., & Christophi, C. (2018) · Oncotarget · doi:10.18632/oncotarget.26174 · Cited by 23
Mauro, N., Scialabba, C., Puleio, R., Varvarà, P., Licciardi, M., Cavallaro, G., & Giammona, G. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.046 · Cited by 23
Cysteine Cathepsins: Potential Applications in Diagnostics and Therapy of Malignant Tumors
Petushkova, A. I., Savvateeva, L. V., Korolev, D. O., & Zamyatnin, A. A. (2019) · Biochemistry (Moscow) · doi:10.1134/s000629791907006x · Cited by 23
Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours
Musa, M. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.12.001 · Cited by 26
The Adhesome Network: Key Components Shaping the Tumour Stroma
Nikolopoulou, P., Koufaki, M. A., & Kostourou, V. (2021) · Cancers · doi:10.3390/cancers13030525 · Cited by 23
Attaran, S., Skoko, J., Hopkins, B., Wright, M. K., Wood, L. E., Asan, A., Woo, H. A., Feinberg, A. W., & Neumann, C. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01510-x · Cited by 22
The “Self-eating” of cancer-associated fibroblast: A potential target for cancer
Chen, Y., Zhang, X., Yang, H., Liang, T., & Bai, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114762 · Cited by 22
Fei, B., Mo, Z., Yang, J., Wang, Z., & Li, S. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s429884 · Cited by 22
Groza, M., Zimța, A., Irimie, A., Achimaș-Cădariu, P., Cenariu, D., Stanta, G., & Berindan‐Neagoe, I. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29096 · Cited by 23
Metadata
- Authors
- Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Hara, Masayasu
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2015-12-11
- Volume
- 7
- Issue
- 4
- Pages
- 2443-2458
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC4695902
- OpenAlex
- W2190528488
- Cited by
- 774
- References
- 125
- Citations by year
- 2026: 29 · 2025: 42 · 2024: 61 · 2023: 71 · 2022: 83 · 2021: 103 · 2020: 121 · 2019: 104 · 2018: 87 · 2017: 49 · 2016: 21
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, tumor-stroma interactions, angiogenesis, interleukin-6, IL-6 receptor, myofibroblasts, drug resistance, tumor progression, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.